← Leaderboards
Daniela M Dinulescu
Massachusetts Institute Of Technology
$2,065,033
Attributed
$5,698,641
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,698,641 · 4
By mechanism
U01$3,531,325 · 1
R01$1,970,228 · 1
R03$170,342 · 1
F32$26,746 · 1
Top collaborators
- Bing Xu7 shared
- Cesar M Castro5 shared
- Hakho Lee5 shared
- Johan Skog5 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Barbara Imperiali$15,091,661
- R. Brad Jones$33,846,824
- Paula T Hammond$10,864,288
- Jacqueline A. Lees$17,361,359
- Paula T Hammond$1,552,964
Others in their field
Top investigators on “Cancer Patient”
- David Heimbrook · Leidos Biomedical Research, Inc.$436,176,488
- Larry Arthur$370,429,903
- Norman Wolmark · Nsabp Foundation, Inc.$324,028,859
- Gregory H Reaman · National Childhood Cancer Foundation$270,366,096
- Leonard Freedman · Leidos Biomedical Research, Inc.$268,085,841
- Richard A Gibbs · Baylor College Of Medicine$240,560,484
Research focus
Cancer PatientMolecularCancer CellMalignant Neoplasm Of OvaryLeadCellsSerousMalignant NeoplasmsDesignBaseOperative Surgical ProceduresInnovationProteinsNanotechnologyMembraneNanoscaleCell Culture TechniquesMouse ModelMalignant Female Reproductive System NeoplasmOvarianOvaryMammalian OviductsIn VitroDiagnostic
Grant awards (15)
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$573,531
U01 · FY2022 · CA
Subcellular enzyme-instructed self-assembly for molecular anticancer nanomedicines$73,705
R01 · FY2022 · CA
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$746,693
U01 · FY2021 · CA
Subcellular Enzyme-instructed self-assembly for molecular anticancer nanomedicines$51,237
R01 · FY2021 · CA
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$746,693
U01 · FY2020 · CA
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$705,145
U01 · FY2019 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$357,100
R01 · FY2019 · CA
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$759,263
U01 · FY2018 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$368,145
R01 · FY2018 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$368,145
R01 · FY2017 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$368,145
R01 · FY2016 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$383,751
R01 · FY2015 · CA
Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer$85,285
R03 · FY2015 · CA · contact PI
Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer$85,057
R03 · FY2014 · CA · contact PI
Mouse Models of Endometriosis and Ovarian Cancer$26,746
F32 · FY2005 · CA